Expression pattern of drug-resistance genes ERG11 and TAC1 in Candida albicans Clinical isolates
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background Candida albicans (C. albicans) is an opportunistic fungus and the most common cause of vulvovaginal candidiasis (VVC). In recent years, the use of antifungal drugs has led to the incidence of drug-resistant C. albicans strains. The purpose of this study is twofold: to determine the pattern of drug susceptibility and the relationship between demographic factors and the incidence of drug resistance among C. albicans isolates and to investigate the expression pattern of drug-resistance genes ERG11 and TAC1 in C. albicans isolates.Methods and results This descriptive cross-sectional study was conducted on 50 C. albicans isolates from women with VVC. Antifungal susceptibility of the isolates was tested by M27-A3/S4 broth micro dilution method following the Clinical and Laboratory Standards Institute (CLSI) guidelines. High susceptibility rates were recorded for itraconazole and voriconazole (68%), followed by ketoconazole (46%). Fluconazole had the lowest susceptibility to C. albicans with susceptibility of 36%. The change in ERG11 and TAC1 genes expression was determined by qPCR. The mean ∆Ct values of ERG11 and TAC1genes were significantly different between fluconazole-resistant and susceptible groups (p < 0.001). Interestingly, we found that 77% of fluconazole-susceptible isolates had significantly upregulated ERG11 gene (2.9-99.0 fold). In addition, the expression of TAC1 was upregulated in 44% of fluconazole-susceptible isolates (3.86-89.8 fold).Conclusion Our finding revealed that incidence of drug resistance in C. albicans is not simply controlled by genes but is a multi-factorial phenomenon, where several factors and mechanisms are involved in the process of drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These mutations lead to either the overexpression of the enzyme itself (14) or alterations in its activity that can lower fluconazole’s binding strength, leading to reduced drug effectiveness (15).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900 · cited 1×
“TAC1 gene is the �rst transcription factor that regulates e�ux pump family genes [32, 33].”
BackgroundAntifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Global burden of recurrent vulvovaginal candidiasis: a systematic review
Denning, D. W., Kneale, M., Sobel, J. D., & Rautemaa-Richardson, R. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30103-8 · Cited by 639
Candidiasis and Mechanisms of Antifungal Resistance
Bhattacharya, S., Sae-Tia, S., & Fries, B. C. (2020) · Antibiotics · doi:10.3390/antibiotics9060312 · Cited by 474
The role of infection in miscarriage
Giakoumelou, S., Wheelhouse, N., Cuschieri, K., Entrican, G., Howie, S. E. M., & Horne, A. W. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv041 · Cited by 464
Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens
Ksiezopolska, E., & Gabaldón, T. (2018) · Genes · doi:10.3390/genes9090461 · Cited by 230
Bitew, A., & Abebaw, Y. (2018) · BMC Women's Health · doi:10.1186/s12905-018-0607-z · Cited by 205
Beardsley, J., Halliday, C. L., Chen, S. C.-A., & Sorrell, T. C. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0059 · Cited by 124
Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon
Liu, T. T., Znaidi, S., Barker, K. S., Xu, L., Homayouni, R., Saidane, S., Morschhäuser, J., Nantel, A., Raymond, M., & Rogers, P. D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00327-07 · Cited by 123
Research works printed but not linked: 2
- Fouladi B, Yadegari M, Rajabibazl M et al (2015) Identification of candida species in patients with vulvovaginitis presenting different clinical symptoms. J Zanjan Univ Med Sci Heal Serv 23:57–68
- Sanglard D, Cacho Teixeira M, Kaushal Tripathi S et al (2017) Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species. Front Microbiol | www frontiersin org 1:2173. https://doi.org/10.3389/fmicb.2016.02173 · DOI · Paper page
Cited by
Molecular association of Candida albicans and vulvovaginal candidiasis: focusing on a solution
David, H., & Solomon, A. P. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1245808 · Cited by 38
Maione, A., Imparato, M., Buonanno, A., Carraturo, F., Schettino, A., Schettino, M. T., Galdiero, M., de Alteriis, E., Guida, M., & Galdiero, E. (2023) · Journal of Fungi · doi:10.3390/jof9030355 · Cited by 28
Nikoomanesh, F., Falahatinejad, M., dos Santos, A. L. S., Rodrigues, C. F., Mohammadi, S. R., Rafiee, M., Rodrigues, C. F., & Roudbary, M. (2023) · Medicina · doi:10.3390/medicina59040743 · Cited by 23
Self-citationZou, P., Liu, J., Li, P., & Luan, Q. (2024) · Antibiotics · doi:10.3390/antibiotics13060521 · Cited by 12
The TAC1 Gene in Candida albicans : Structure, Function, and Role in Azole Resistance: A Mini-Review
Mahdizade, A. H., Hoseinnejad, A., Ghazanfari, M., Boozhmehrani, M. J., Bahreiny, S. S., Abastabar, M., Galbo, R., Giuffrè, L., Haghani, I., & Romeo, O. (2024) · Microbial Drug Resistance · doi:10.1089/mdr.2023.0334 · Cited by 12
Metadata
- Authors
- Zare-Bidaki, M., Maleki, A., Ghanbarzadeh, N., & Nikoomanesh, F.
- Affiliations
- Birjand University of Medical Sciences (IR)
- Corresponding author
- Nikoomanesh, Fatemeh
- Venue
- Molecular Biology Reports
- Published
- 2022-09-28
- Volume
- 49
- Issue
- 12
- Pages
- 11625-11633
- ISSN
- 0301-4851 (ISSN-L)
- 1573-4978
- OpenAlex
- W4297461470
- Cited by
- 15
- References
- 39
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 1
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Biology Reports (publishedVersion)
- Research Square (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida albicans, antifungal resistance, ERG11, TAC1, gene expression, vaginal candidiasis, fluconazole resistance, antifungal susceptibility, ketoconazole, itraconazole, voriconazole, clinical isolates
- MeSH terms
- Antifungal Agents, Candida albicans, Cross-Sectional Studies, Female, Humans, Microbial Sensitivity Tests, Fluconazole, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression pattern of drug-resistance genes ERG11 and TAC1 in Candida albicans Clinical isolates. https://app.cochat.ai/papers/10.1007/s11033-022-07878-0
- The paper
- Zare-Bidaki, M., Maleki, A., Ghanbarzadeh, N., & Nikoomanesh, F. (2022). Expression pattern of drug-resistance genes ERG11 and TAC1 in Candida albicans Clinical isolates. Molecular Biology Reports. https://doi.org/10.1007/s11033-022-07878-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.